CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
;
Sarah
Maguire
;
Anna
Morra
;
Pooja Middha
Kapoor
;
Katarzyna
Tomczyk
;
Michael E
Jones
;
Minouk J
Schoemaker
;
Clare
Gilham
;
Manjeet K
Bolla
;
Qin
Wang
;
+142 more...
Joe
Dennis
;
Thomas U
Ahearn
;
Irene L
Andrulis
;
Hoda
Anton-Culver
;
Natalia N
Antonenkova
;
Volker
Arndt
;
Kristan J
Aronson
;
Annelie
Augustinsson
;
Caroline
Baynes
;
Laura E Beane
Freeman
;
Matthias W
Beckmann
;
Javier
Benitez
;
Marina
Bermisheva
;
Carl
Blomqvist
;
Bram
Boeckx
;
Natalia V
Bogdanova
;
Stig E
Bojesen
;
Hiltrud
Brauch
;
Hermann
Brenner
;
Barbara
Burwinkel
;
Daniele
Campa
;
Federico
Canzian
;
Jose E
Castelao
;
Stephen J
Chanock
;
Georgia
Chenevix-Trench
;
Christine L
Clarke
;
NBCS Collaborators
;
Don M
Conroy
;
Fergus J
Couch
;
Angela
Cox
;
Simon S
Cross
;
Kamila
Czene
;
Thilo
Dörk
;
A Heather
Eliassen
;
Christoph
Engel
;
D Gareth
Evans
;
Peter A
Fasching
;
Jonine
Figueroa
;
Giuseppe
Floris
;
Henrik
Flyger
;
Manuela
Gago-Dominguez
;
Susan M
Gapstur
;
Montserrat
García-Closas
;
Mia M
Gaudet
;
Graham G
Giles
;
Mark S
Goldberg
;
Anna
González-Neira
;
AOCS Group
;
Pascal
Guénel
;
Eric
Hahnen
;
Christopher A
Haiman
;
Niclas
Håkansson
;
Per
Hall
;
Ute
Hamann
;
Patricia A
Harrington
;
Steven N
Hart
;
Maartje J
Hooning
;
John L
Hopper
;
Anthony
Howell
;
David J
Hunter
;
ABCTB Investigators
;
kConFab Investigators
;
Agnes
Jager
;
Anna
Jakubowska
;
Esther M
John
;
Rudolf
Kaaks
;
Renske
Keeman
;
Elza
Khusnutdinova
;
Cari M
Kitahara
;
Veli-Matti
Kosma
;
Stella
Koutros
;
Peter
Kraft
;
Vessela N
Kristensen
;
Allison W
Kurian
;
Diether
Lambrechts
;
Loic
Le Marchand
;
Martha
Linet
;
Jan
Lubiński
;
Arto
Mannermaa
;
Siranoush
Manoukian
;
Sara
Margolin
;
John WM
Martens
;
Dimitrios
Mavroudis
;
Rebecca
Mayes
;
Alfons
Meindl
;
Roger L
Milne
;
Susan L
Neuhausen
;
Heli
Nevanlinna
;
William G
Newman
;
Sune F
Nielsen
;
Børge G
Nordestgaard
;
Nadia
Obi
;
Andrew F
Olshan
;
Janet E
Olson
;
Håkan
Olsson
;
Ester
Orban
;
Tjoung-Won
Park-Simon
;
Paolo
Peterlongo
;
Dijana
Plaseska-Karanfilska
;
Katri
Pylkäs
;
Gad
Rennert
;
Hedy S
Rennert
;
Kathryn J
Ruddy
;
Emmanouil
Saloustros
;
Dale P
Sandler
;
Elinor J
Sawyer
;
Rita K
Schmutzler
;
Christopher
Scott
;
Xiao-Ou
Shu
;
Jacques
Simard
;
Snezhana
Smichkoska
;
Christof
Sohn
;
Melissa C
Southey
;
John J
Spinelli
;
Jennifer
Stone
;
Rulla M
Tamimi
;
Jack A
Taylor
;
Rob AEM
Tollenaar
;
Ian
Tomlinson
;
Melissa A
Troester
;
Thérèse
Truong
;
Celine M
Vachon
;
Elke M
van Veen
;
Sophia S
Wang
;
Clarice R
Weinberg
;
Camilla
Wendt
;
Hans
Wildiers
;
Robert
Winqvist
;
Alicja
Wolk
;
Wei
Zheng
;
Argyrios
Ziogas
;
Alison M
Dunning
;
Paul DP
Pharoah
;
Douglas F
Easton
;
A Forbes
Howie
;
Julian
Peto
;
Isabel
Dos-Santos-Silva
;
Anthony J
Swerdlow
;
Jenny
Chang-Claude
;
Marjanka K
Schmidt
;
Nick
Orr
;
Olivia
Fletcher
;
(2021)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
British journal of cancer, 124 (4).
pp. 842-854.
ISSN 0007-0920
DOI: 10.1038/s41416-020-01185-w
BACKGROUND: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk. METHODS: We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry. RESULTS: For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (-49.2%, 95% CI -56.1% to -41.1%, P = 3.1 × 10-18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (-26.7%, 95% CI -39.4% to -11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82-0.91, P = 6.9 × 10-8). CONCLUSIONS: The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.
-
picture_as_pdf - s41416-020-01185-w.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0